Clinical Trials Browser

Phase NA × Rosiglitazone × Endocrine × Clear all

NCT03309319 2017-10-13

A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

Phase NA Unknown

Pituitary Neoplasms